ELOX Eloxx Pharmaceuticals Inc.

10.57
-0.38  -3%
Previous Close 10.95
Open 11.17
Price To Book 11.01
Market Cap 380788711
Shares 36,025,422
Volume 31,576
Short Ratio
Av. Daily Volume 28,584

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1b MAD final cohort data due May 2019.
ELX-02
Multiple-ascending dose (MAD)
Phase 2 data due 2019.
ELX-02
Cystic fibrosis

Latest News

  1. SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Eloxx Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
  2. Edited Transcript of ELOX earnings conference call or presentation 9-May-19 12:30pm GMT
  3. Eloxx Pharmaceuticals, Inc. (ELOX) Q1 2019 Earnings Call Transcript
  4. Eloxx Pharmaceuticals Reports First Quarter 2019 Financial and Operating Results and Provides Business Update
  5. Eloxx Pharmaceuticals Presents Positive New Data at the Association for Research in Vision and Ophthalmology “ARVO” 2019 Annual Meeting
  6. Eloxx Pharmaceuticals to Report First Quarter 2019 Financial Results and Provide Business Update on May 9, 2019
  7. Eloxx Pharmaceuticals to Participate in the 2019 5th Annual SunTrust Robinson Humphrey (STRH) Life Sciences Summit on May 7, 2019
  8. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by the Board of Directors of Eloxx Pharmaceuticals, Inc.
  9. Eloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the European Cystic Fibrosis Society (ECFS) Basic Science Conference
  10. Proteostasis Plunges on Weak Data From Cystic Fibrosis Study
  11. Eloxx Pharmaceuticals to Present at the Guggenheim Rare Disease & Genomic Medicines Day on April 2, 2019
  12. Edited Transcript of ELOX earnings conference call or presentation 8-Mar-19 1:00pm GMT
  13. Eloxx Pharmaceuticals, Inc. (ELOX) Q4 2018 Earnings Conference Call Transcript
  14. Eloxx Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial and Operating Results and Provides Business Update
  15. Eloxx Pharmaceuticals to Present at the Oppenheimer 29th Annual Healthcare Conference on March 20, 2019
  16. Eloxx Pharmaceuticals Announces Participation in the HIT-CF Project on Cystic Fibrosis
  17. Eloxx Pharmaceuticals to Present at the Barclays Global Healthcare Conference on March 14, 2019
  18. Eloxx Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference on Monday, March 11, 2019
  19. Eloxx Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference in New York City on Friday, March 1, 2019